Frontiers in Cardiovascular Medicine

Brief Research Report

Published on 23 Feb 2021

Vascular Inflammation and Cardiovascular Burden in Metastatic Breast Cancer Female Patients Receiving Hormonal Treatment and CDK 4/6 Inhibitors or Everolimus

in Cardio-Oncology

Christos Papageorgiou
Flora Zagouri
Konstantinos Tampakis
Rebecca Georgakopoulou
Efstathios Manios
Pavlos Kafouris
Georgios Benetos
Iosif Koutagiar
Constantinos Anagnostopoulos
Meletios A. Dimopoulos

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.638895

4,034 views
14 citations

Original Research

Published on 23 Feb 2021

The Effects of Repeat-Dose Doxorubicin on Cardiovascular Functional Endpoints and Biomarkers in the Telemetry-Equipped Cynomolgus Monkey

in Cardio-Oncology

Michael J. Engwall
Nancy Everds
James R. Turk
Hugo M. Vargas

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.587149

3,965 views
6 citations

Mini Review

Published on 03 Feb 2021

Immune Checkpoint Inhibitors: Cardiotoxicity in Pre-clinical Models and Clinical Studies

in Cardio-Oncology

Shirley Xu
Umesh C. Sharma
Cheyanna Tuttle
Saraswati Pokharel

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.619650

6,684 views
22 citations

Original Research

Published on 01 Feb 2021

Sunitinib and Imatinib Display Differential Cardiotoxicity in Adult Rat Cardiac Fibroblasts That Involves a Role for Calcium/Calmodulin Dependent Protein Kinase II

in Cardio-Oncology

Calum J. McMullen
Susan Chalmers
Rachel Wood
Margaret R. Cunningham
Susan Currie

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2020.630480

6,204 views
15 citations

Original Research

Published on 22 Jan 2021

Cancer Radiation Therapy May Be Associated With Atrial Fibrillation

in Cardio-Oncology

Nachiket Apte
Parinita Dherange
Usman Mustafa
Lina Ya'qoub
Desiree Dawson
Kathleen Higginbotham
Marjan Boerma
Daniel P. Morin
Dipti Gupta
Jerry McLarty

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.610915

10,653 views
25 citations

Case Report

Published on 15 Jan 2021

Case Report: Thromboembolism and Hemorrhagic Pericardial Effusion—The Janus Face of Primary Pericardial Angiosarcoma

in Cardio-Oncology

Fei F. Chen
Shu F. Jiang
Chang Dong
Ying Che
Lin Y. Du
Zhi Y. Li
Zhi Q. Yang
Yi C. Zhao
Ying Liu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2020.618146

3,774 views
2 citations

Case Report

Published on 04 Dec 2020

Case Report: Neuroendocrine Tumor With Cardiac Metastasis

in Cardio-Oncology

Rachel E. Kinney
Robert Decker
Deborah Sundlof
Muhammad A. Rizvi
Kelly Schadler

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2020.596921

6,009 views
8 citations

Perspective

Published on 04 Dec 2020

Pandemic Perspective: Commonalities Between COVID-19 and Cardio-Oncology

in Cardio-Oncology

Sherry-Ann Brown
Svetlana Zaharova
Peter Mason
Jonathan Thompson
Bicky Thapa
David Ishizawar
Erin Wilkes
Gulrayz Ahmed
Jason Rubenstein
Joyce Sanchez

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2020.568720

4,821 views
5 citations

Mini Review

Published on 25 Nov 2020

Cardio-Oncology: Learning From the Old, Applying to the New

in Cardio-Oncology

Jun-ichi Abe
Syed Wamique Yusuf
Anita Deswal
Joerg Herrmann

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2020.601893

4,335 views
8 citations

Systematic Review

Published on 12 Nov 2020

Net Clinical Benefit of Direct Oral Anticoagulants in Patients With Cancer and Venous Thromboembolism: A Systematic Review and Trade-Off Analysis

in Cardio-Oncology

Yi-Dan Yan
Zheng Ding
Mang-Mang Pan
Qing Xia
Jiu-Jie Cui
Li-Wei Wang
Chi Zhang
Zhi-Chun Gu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2020.586020

4,167 views
8 citations

Original Research

Published on 30 Oct 2020

Red Blood Cell Distribution Width Is a Predictive Factor of Anthracycline-Induced Cardiotoxicity

in Cardio-Oncology

Daiki Yaegashi
Masayoshi Oikawa
Tetsuro Yokokawa
Tomofumi Misaka
Atsushi Kobayashi
Takashi Kaneshiro
Akiomi Yoshihisa
Kazuhiko Nakazato
Takafumi Ishida
Yasuchika Takeishi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2020.594685

9,403 views
5 citations

Mini Review

Published on 26 Oct 2020

Development of Cancer in Patients With Heart Failure: How Systemic Inflammation Can Lay the Groundwork

in Cardio-Oncology

Simonetta Ausoni
Giuseppe Azzarello

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2020.598384

4,245 views
21 citations

Original Research

Published on 26 Oct 2020

Development and Validation of a New Clinical Prediction Model of Catheter-Related Thrombosis Based on Vascular Ultrasound Diagnosis in Cancer Patients

in Cardio-Oncology

Binliang Liu
Junying Xie
Xiaoying Sun
Yanfeng Wang
Zhong Yuan
Xiyu Liu
Zhou Huang
Jiani Wang
Hongnan Mo
Zongbi Yi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2020.571227

3,989 views
12 citations

Editorial

Published on 26 Aug 2020

Editorial: Emerging Challenges of Cardiovascular and Metabolic Dysfunctions in Cardio-Oncology: From Bench to Bedside

in Cardio-Oncology

Canan G. Nebigil
Michael W. Y. Chan
Tienush Rassaf

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2020.00148

2,357 views
1 citation

Opinion

Published on 14 Aug 2020

Innovation in Precision Cardio-Oncology During the Coronavirus Pandemic and Into a Post-pandemic World

in Cardio-Oncology

Sherry-Ann Brown
June-Wha Rhee
Avirup Guha
Vijay U. Rao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2020.00145

8,237 views
24 citations

Original Research

Published on 13 Aug 2020

Association of Genetic Variants at TRPC6 With Chemotherapy-Related Heart Failure

in Cardio-Oncology

Nadine Norton
Julia E. Crook
Liwei Wang
Janet E. Olson
Jennifer M. Kachergus
Daniel J. Serie
Brian M. Necela
Paul G. Borgman
Pooja P. Advani
Jordan C. Ray

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2020.00142

5,237 views
13 citations

Navigation group

Articles

Vascular Inflammation and Cardiovascular Burden in Metastatic Breast Cancer Female Patients Receiving Hormonal Treatment and CDK 4/6 Inhibitors or Everolimus

The Effects of Repeat-Dose Doxorubicin on Cardiovascular Functional Endpoints and Biomarkers in the Telemetry-Equipped Cynomolgus Monkey

Immune Checkpoint Inhibitors: Cardiotoxicity in Pre-clinical Models and Clinical Studies

Sunitinib and Imatinib Display Differential Cardiotoxicity in Adult Rat Cardiac Fibroblasts That Involves a Role for Calcium/Calmodulin Dependent Protein Kinase II

Cancer Radiation Therapy May Be Associated With Atrial Fibrillation

Case Report: Thromboembolism and Hemorrhagic Pericardial Effusion—The Janus Face of Primary Pericardial Angiosarcoma

Case Report: Neuroendocrine Tumor With Cardiac Metastasis

Pandemic Perspective: Commonalities Between COVID-19 and Cardio-Oncology

Cardio-Oncology: Learning From the Old, Applying to the New

Net Clinical Benefit of Direct Oral Anticoagulants in Patients With Cancer and Venous Thromboembolism: A Systematic Review and Trade-Off Analysis

Red Blood Cell Distribution Width Is a Predictive Factor of Anthracycline-Induced Cardiotoxicity

Development of Cancer in Patients With Heart Failure: How Systemic Inflammation Can Lay the Groundwork

Development and Validation of a New Clinical Prediction Model of Catheter-Related Thrombosis Based on Vascular Ultrasound Diagnosis in Cancer Patients

Editorial: Emerging Challenges of Cardiovascular and Metabolic Dysfunctions in Cardio-Oncology: From Bench to Bedside

Innovation in Precision Cardio-Oncology During the Coronavirus Pandemic and Into a Post-pandemic World

Association of Genetic Variants at TRPC6 With Chemotherapy-Related Heart Failure